“Where I End And You Begin”: A personal commentary on Russo’s ‘Through the eyes of the observed’ #PsychDrugDebate

Screen Shot 2018-07-23 at 12.59.20

Sarah Carr shares her own experiences of psychiatric medication and provides a critical reading of Jasna Russo’s new #PsychDrugDebate paper: ‘Through the eyes of the observed: re-directing the research on psychiatric drugs’.

[read the full story...]

How should we redirect research on psychiatric drugs? #PsychDrugDebate

image001-1

Alison Faulkner dissects the new McPin Foundation Talking Point Paper by Jasna Russo entitled: Through the eyes of the observed: re-directing research on psychiatric drugs.

Follow #PsychDrugDebate today on Twitter for further discussion about this vital issue.

[read the full story...]

Commonly prescribed psychiatric drugs: do they work?

4932655275_7811863fe8_o

John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.

[read the full story...]

Enteral feeding tube guidelines not followed in residential settings

tablets_shutterstock_114851935 (2)

For some people with learning disabilities, difficulties in eating and swallowing mean that enteral tubes are used to consume food and sometimes to take medication.

Here, Fawn Harrad looks at a Belgian study in which researchers observed whether staff in residential settings were following guidelines in the use of enteral feeding tubes to administer medications.

[read the full story...]

Direct training with accessible materials improves knowledge of medication and capacity to consent in small group of adults with learning disabilities

Health information

People with learning disabiilties may be on multiple medications and be on them for long periods of time. They need access to the best possible support to help them make decisions about their medications. In this post, we look at an action research study that offered training to people to see if it improved their knowledge and their capacity to consent.

[read the full story...]

35% of people with learning disabilities in Australian city prescribed psychotropic medications

medicine in blisterpack

It is estimated that in UK, up to 200,000 people with learning disabilities are given anti-psychotic drugs, which can have powerful side effects, like risk of weight gain, impotence and strain to the cardiovascular system, and with little evidence of their efficacy in treating challenging behaviour. There are equal concerns about the use of anti-convulsant [read the full story…]

People with learning disabilities still not getting adequate information and support to make decisions about medications

Health information

Making the decision to consent to medical treatment requires access to information, presented in clear and understandable ways. There is evidence that that people with learning disabilities do not always understand information about medications they are prescribed, for example from the medication matters project carried out at the Norah Fry centre  which produced a series of [read the full story…]

Psychiatric outpatients clinic improves prescribing of medication in people with learning disabilities

medicine in blisterpack

Many studies have looked at the difficulties associated with medication management in people with learning disabilities. This study set out to looked at an approach to medication management and treatment in an outpatient psychiatry clinic for 198 community-residing children and adults with learning disability who were referred to the clinic and subsequently discharged over an [read the full story…]

Methodological difficulties continue to hamper evaluation of interventions for challenging behaviour

Meeting

The authors of this study set out to evaluate behavioural and medication-based interventions in the treatment of challenging behaviour in people learning disabilities, both separately and in combination. They suggest that researchers might need to adapt the methods they have traditionally used to evaluate drug interventions for individuals without disabilities when working with people with [read the full story…]